Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 290

1.

Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments.

Zuo L, Prather ER, Stetskiv M, Garrison DE, Meade JR, Peace TI, Zhou T.

Int J Mol Sci. 2019 Sep 10;20(18). pii: E4472. doi: 10.3390/ijms20184472. Review.

2.

Competitive α-glucosidase inhibitors, dihydrobenzoxanthones, from the barks of Artocarpus elasticus.

Jenis J, Baiseitova A, Yoon SH, Park C, Kim JY, Li ZP, Lee KW, Park KH.

J Enzyme Inhib Med Chem. 2019 Dec;34(1):1623-1632. doi: 10.1080/14756366.2019.1660653.

3.

Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase 3 Expression.

Kuo WT, Shen L, Zuo L, Shashikanth N, Ong MLDM, Wu L, Zha J, Edelblum KL, Wang Y, Wang Y, Nilsen SP, Turner JR.

Gastroenterology. 2019 Aug 8. pii: S0016-5085(19)41200-6. doi: 10.1053/j.gastro.2019.07.058. [Epub ahead of print]

PMID:
31401143
4.

Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.

Viecelli AK, Howell M, Tong A, Teixeira-Pinto A, O'Lone E, Ju A, Craig JC, Hooi LS, Lee T, Lok CE, Polkinghorne KR, Quinn RR, Vachharajani TJ, Vanholder R, Zuo L, Tordoir J, Pecoits-Filho R, Yuo T, Kopperschmidt P, Smith R, Irish AB, Mori TA, Pascoe EM, Johnson DW, Hawley CM.

Nephrol Dial Transplant. 2019 Aug 1. pii: gfz148. doi: 10.1093/ndt/gfz148. [Epub ahead of print]

PMID:
31369099
5.

Assessing Anthocyanin Biosynthesis in Solanaceae as a Model Pathway for Secondary Metabolism.

Li Z, Vickrey TL, McNally MG, Sato SJ, Clemente TE, Mower JP.

Genes (Basel). 2019 Jul 25;10(8). pii: E559. doi: 10.3390/genes10080559.

6.

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.

Chen N, Hao C, Liu BC, Lin H, Wang C, Xing C, Liang X, Jiang G, Liu Z, Li X, Zuo L, Luo L, Wang J, Zhao MH, Liu Z, Cai GY, Hao L, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP.

N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24.

PMID:
31340116
7.

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.

Chen N, Hao C, Peng X, Lin H, Yin A, Hao L, Tao Y, Liang X, Liu Z, Xing C, Chen J, Luo L, Zuo L, Liao Y, Liu BC, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP.

N Engl J Med. 2019 Sep 12;381(11):1001-1010. doi: 10.1056/NEJMoa1813599. Epub 2019 Jul 24.

PMID:
31340089
8.

Different type and dosage of heparin were not associated with the progression of coronary artery calcification in haemodialysis patients.

Niu Q, Yang S, Gan L, Zhao H, Zuo L.

Nephrology (Carlton). 2019 Jul 24. doi: 10.1111/nep.13632. [Epub ahead of print]

PMID:
31339604
9.

Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study.

Zhan Z, Smyth B, Toussaint ND, Gray NA, Zuo L, de Zoysa JR, Chan CT, Jin C, Scaria A, Hawley CM, Perkovic V, Jardine MJ, Zhang L.

BMC Nephrol. 2019 Jul 12;20(1):258. doi: 10.1186/s12882-019-1438-3.

10.

CDKN1B Val 109 Gly variant is not related to risk of prostate cancer.

Zhu L, Wang J, Yue C, Yuan W, Zhang W, Shi L, Mi Y, Wu X, Zhang LF, Zuo L.

J Cell Biochem. 2019 Oct;120(10):18346-18356. doi: 10.1002/jcb.29144. Epub 2019 Jun 30.

PMID:
31257659
11.

Human neutrophil elastase (HNE) inhibitory polyprenylated acylphloroglucinols from the flowers of Hypericum ascyron.

Li ZP, Kim JY, Ban YJ, Park KH.

Bioorg Chem. 2019 Sep;90:103075. doi: 10.1016/j.bioorg.2019.103075. Epub 2019 Jun 20.

PMID:
31254671
12.

The Protective Roles of Estrogen Receptor β in Renal Calcium Oxalate Crystal Formation via Reducing the Liver Oxalate Biosynthesis and Renal Oxidative Stress-Mediated Cell Injury.

Zhu W, Zhao Z, Chou FJ, Zuo L, Liu T, Bushinsky D, Chang C, Zeng G, Yeh S.

Oxid Med Cell Longev. 2019 Apr 17;2019:5305014. doi: 10.1155/2019/5305014. eCollection 2019.

13.

Expression of ICOSL is associated with decreased survival in invasive breast cancer.

Wang B, Jiang H, Zhou T, Ma N, Liu W, Wang Y, Zuo L.

PeerJ. 2019 May 16;7:e6903. doi: 10.7717/peerj.6903. eCollection 2019.

14.

Assessment of chronic renal injury in patients with chronic myeloid leukemia in the chronic phase receiving tyrosine kinase inhibitors.

Ren X, Qin Y, Huang X, Zuo L, Jiang Q.

Ann Hematol. 2019 Jul;98(7):1627-1640. doi: 10.1007/s00277-019-03690-2. Epub 2019 May 14.

PMID:
31089794
15.

Phytochemical analysis of aerial part of Ikonnikovia kaufmanniana and their protection of DNA damage.

Baiseitova A, Jenis J, Kim JY, Li ZP, Park KH.

Nat Prod Res. 2019 May 14:1-4. doi: 10.1080/14786419.2019.1607858. [Epub ahead of print]

PMID:
31084209
16.

New insights into the association between AXIN2 148 C/T, 1365 C/T, and rs4791171 A/G variants and cancer risk.

Xu B, Yuan W, Shi L, Zuo L, Wu XY, Zhang W, Wen Q.

Cancer Cell Int. 2019 May 6;19:119. doi: 10.1186/s12935-019-0840-z. eCollection 2019.

17.

The association between three AXIN2 variants and cancer risk.

Dai F, Zhu LJ, Zhang W, Mi YY, Sun HY, Zhang LF, Yue C, Wu XY, Zuo L, Bai Y.

J Cell Biochem. 2019 Sep;120(9):15561-15571. doi: 10.1002/jcb.28823. Epub 2019 Apr 30.

PMID:
31038806
18.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.

Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators.

Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Erratum in: Lancet. 2019 May 11;393(10184):1936.

PMID:
30995972
19.

Commentaries on Viewpoint: Managing the power grid: How myoglobin can regulate Po2 and energy distribution in skeletal muscle.

Bock JM, Kruse NT, Donnelly C, Hirai DM, Craig JC, Colburn TD, Musch TI, Poole DC, Rosenberry R, Tian F, Liu H, Nelson MD, Piknova B, Willis WT, Zuo L, Zhou T, Riveros-Rivera A, Cristancho E, Gunga HC.

J Appl Physiol (1985). 2019 Mar 1;126(3):791-794. doi: 10.1152/japplphysiol.01107.2018. No abstract available.

PMID:
30907709
20.

Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals.

Zhu W, Zhao Z, Chou F, Zuo L, Liu T, Yeh S, Bushinsky D, Zeng G, Chang C.

Cell Death Dis. 2019 Mar 20;10(4):275. doi: 10.1038/s41419-019-1358-y.

Supplemental Content

Loading ...
Support Center